The objective is to investigate the interaction of sclero-embolic and contrast agents with the polymerisation of medical grade n-butyl-cyanoacrylates.
Methods
An in vitro spectrophotometric absorbance method was developed to detect changes in light transmission to measure n-BCA polymerisation. The initiation and the rate-of-polymerisation of mixtures of n-BCA with sclero-embolic and contrast agents were investigated.
Results
Initiation of polymerisation: VENABLOCK™ and HISTOACRYL® were the fastest agents to polymerise, while VENASEAL™ was the slowest. Rate of polymerisation: Hypertonic saline inhibited the polymerisation of all n-BCAs, while hypertonic glucose prolonged the polymerisation rate. ETHANOL and detergent sclerosants had no effect. Contrast agents OMNIPAQUE™ and ULTRAVIST® initiated and prolonged the polymerisation of n-BCA, but in contrast, LIPIODOL® failed to initiate the process.
Conclusions
The commercially available medical cyanoacrylates differ in their polymerisation rates. These polymerisation rates are further affected when these products are used in conjunction with other compounds, such as sclero-embolic and contrast agents.
YakesWFYakesAMVogelzangRL, et al.Endovascular treatment of vascular malformation: an overview. In: KimY-WLeeB-BYakesWF, et al. (eds) Congenital vascular malformations: a comprehensive review of current management. Berlin, Heidelberg: Springer, 2017, pp. 197–209.
2.
LeeB-BDoYSYakesW, et al.Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg2004; 39: 590–600.
3.
BrothersMFKaufmannJCFoxAJ, et al.N-Butyl 2-cyanoacrylate--substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. Am J Neuroradiol1989; 10: 777–786.
4.
ParsiKRobertsSKangM, et al.Cyanoacrylate closure for peripheral veins: consensus document of the Australasian college of phlebology. Phlebology2020; 35: 153–175.
5.
RozenshteynFHermanMCollinsK, et al.2020A comparative study of the efficacy of endoscopic injection of cyanoacrylate glue vs other interventional modalities for treatment of acute gastric variceal bleeding: a systematic review and meta-analysis. Am J Gastroenterol2020; 115: S318.
6.
KerberCBankWCromwellL. Calibrated leak balloon microcatheter: a device for arterial exploration and occlusive therapy. Am J Roentgenol1979; 132: 207–212.
7.
KerberCWCromwellLDLoehdenOL. Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. AJNR Am J Neuroradiol1980; 1: 348–349.
HillHChickJFBHageA, et al.N-butyl cyanoacrylate embolotherapy: techniques, complications, and management. Diagn Interv Radiol2018; 24: 98–103.
10.
TakeuchiYMorishitaHSatoY, et al.Guidelines for the use of NBCA in vascular embolization devised by the committee of practice guidelines of the japanese society of interventional radiology (CGJSIR). Jpn J Radiol2014; 32: 500–517. 2012 edition.
11.
LoffroyRCombyP-OGuillenK, et al.N-Butyl cyanoacrylate–lipiodol mixture for endovascular purpose: polymerization kinetics differences between in vitro and in vivo experiments. Cardiovasc Intervent Radiol2020; 43: 1409–1410.
12.
HollasJM. Modern spectroscopy. Hoboken, NJ: Wiley, 2013.
13.
GuillenKCombyP-OChevallierO, et al.In vivo experimental endovascular uses of cyanoacrylate in non-modified arteries: a systematic review. Biomedicines2021; 9: 1282.
14.
DuffyCZetterlundPBAldabbaghF. Radical polymerization of Alkyl 2-cyanoacrylates. Molecules2018; 23: 465.
15.
TsengYMaLLuoT, et al.Thromboembolic events secondary to endoscopic cyanoacrylate injection: can we foresee any red flags?Chin J Gastroenterol Hepatol2018; 2018: e1940592.
16.
LiYJBarthès-BieselDSalsacA-V. Polymerization kinetics of n-butyl cyanoacrylate glues used for vascular embolization. J Mech Behav Biomed Mater2017; 69: 307–317.
17.
JordanODoelkerERüfenachtDA. Biomaterials used in injectable implants (liquid embolics) for percutaneous filling of vascular spaces. Cardiovasc Intervent Radiol2005; 28: 561–569.
18.
PalABlanzyJGómezKJR, et al.Liquid embolic agents for endovascular embolization: a review. Gels2023; 9: 378.
19.
KawaiNSatoMMinamiguchiH, et al.Basic study of a mixture of N-butyl cyanoacrylate, ethanol, and lipiodol as a new embolic material. J Vasc Intervent Radiol2012; 23: 1516–1521.
20.
CombyP-OGuillenKChevallierO, et al.Endovascular use of cyanoacrylate-lipiodol mixture for peripheral embolization: properties, techniques, pitfalls, and applications. J Clin Med2021; 10: 4320.
21.
AbdullahASachithanandanSTanOK, et al.Cerebral embolism following N-butyl-2-cyanoacrylate injection for esophageal postbanding ulcer bleed: a case report. Hepatol Int2009; 3: 504–508.
22.
GraceJConnorDEBesterLJ, et al.Polymerisation of cyanoacrylates: the effect of sclero-embolic and contrast agents. Chatswood, NSW: Phlebology. in press.
23.
TessariLTessariM. Foam-glue syringe a new device for varicose veins treatment. Phlebology2022; 37: S31.
24.
SpiegelSMViñuelaFGoldwasserJM, et al.Adjusting the polymerization time of isobutyl-2 cyanoacrylate. Am J Neuroradiol1986; 7: 109–112.
25.
RaoVRMandalamKRGuptaAK, et al.Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up. AJNR Am J Neuroradiol1989; 10: 135–141.
26.
BrasselFMeilaD. Evolution of embolic agents in interventional neuroradiology. Clin Neuroradiol2015; 25(Suppl 2): 333–339.
27.
MizrahiBStefanescuCFYangC, et al.Elasticity and safety of alkoxyethyl cyanoacrylate tissue adhesives. Acta Biomater2011; 7: 3150–3157.
28.
MineTYasuiDSaitoH, et al.Effects of temperature alteration on viscosity, polymerization, and in-vivo arterial distribution of N-butyl cyanoacrylate-iodized oil mixtures. Jpn J Radiol2021; 39: 1111–1118.
29.
ChoSGibsonKLeeSH, et al.Incidence, classification, and risk factors of endovenous glue-induced thrombosis after cyanoacrylate closure of the incompetent saphenous vein. J Vasc Surg Venous Lymphat Disord2020; 8: 991–998.
30.
PillutlaAHendrixMPHaJ. Endovenous glue-induced thrombosis in nonthermal glue closure therapy for greater saphenous vein insufficiency: a single-center experience. J Vasc Intervent Radiol2019; 30: 1075–1080.
31.
JungJYLeeJY. Transvenous injection of n-butyl 2-cyanoacrylate to obliterate the pathologic cavernous sinus as a salvage technique for incompletely obliterated complex cavernous sinus dural arteriovenous fistula after transvenous coil embolization. J Cerebrovasc Endovasc Neurosurg2021; 23: 348–353.
WangBHBoultonMLeeDH, et al.A systematic characterization of the factors influencing polymerization and dynamic behavior of n-butyl cyanoacrylate. J Neurointerventional Surg2018; 10: 150–155.
35.
OowakiHMatsudaSSakaiN, et al.Non-adhesive cyanoacrylate as an embolic material for endovascular neurosurgery. Biomaterials2000; 21: 1039–1046.
36.
Chemence Medical, Inc. HISTOACRYL® and HISTOACRYL® BLUE TOPICAL SKIN ADHESIVE. [Package Insert], Alpharetta, GA: B. Braun Australia Pty. Ltd, 2022.
37.
MattickA. Use of tissue adhesives in the management of paediatric lacerations. Emerg Med J2002; 19: 382–385.
38.
PenoffJ. Skin closures using cyanoacrylate tissue adhesives. Plastic surgery educational foundation DATA committee. Device and technique assessment. Plast Reconstr Surg 19631999; 103: 730–731.
39.
BozkurtAKYılmazMF. A prospective comparison of a new cyanoacrylate glue and laser ablation for the treatment of venous insufficiency. Phlebology2016; 31: 106–113.
